All News

Restaurant

The 16th Annual La Paulee

d William Julius Shergy

La Paulee is traditionally the party/feast after harvest and a time when hard work is rewarded with food, fun, and wine. And so it was that evening; after better understanding genes, cytokines, and pathology it was time to have a good time with friends, old and new.

Read Article
Screen%20Shot%202018-10-24%20at%203.40.08%20PM.png

Checkpoint Inhibitor-related Myositis – Something Different

d Cassandra Calabrese, DO

As expected, this year’s ACR meeting saw an upswing in the number of abstracts on immune related adverse events from checkpoint inhibitor therapy compared to last year.

Read Article
Final presentation of #ACR18 - Marissa Lassere presenting #ARAD data on opioid use in Australians with inflammatory arthritis. Use of high-potency opioids more likely in socioeconomically disadvantaged RA patients. #SDOH @RheumNow

ǝlʇʇıɥʍ ɯɐs samwhittle ( View Tweet)

Bimekizimab phase 2 presented at #ACR18 with extremely impressive results for joints and skin improvement (in fact the primary outcome was ACR50!!!).... game changer? @RheumNow https://t.co/3lKkIMiSCI

Links:

Arthur Lau ArthurRheum ( View Tweet)

Pooled analysis from 3 PSA+12 PSO trials on ixekizumab RCTs. Reassuring that incidence of IBD relatively low with significant pt year f/u (https://t.co/icWfGIEnxt @RheumNow #ACR18

Links:

Arthur Lau ArthurRheum ( View Tweet)

Now available: https://t.co/QrHTupEmaN. #acr18 https://t.co/N7dWlp3zz2

Links:

Dr. John Cush RheumNow ( View Tweet)

SEAM PSA study: wow MTX monotherapy was surprisingly good for ACR scores (ETN clearly better especially for high bar outcomes, but not too shabby at all for MTX mono) https://t.co/dc2vYFs8pY @RheumNow #ACR18

Links:

Arthur Lau ArthurRheum ( View Tweet)

ETN plus MTX combo better for skin PSO outcomes, but not a huge improvement for joints... but remember this study used ETN 50 q week (not twice weekly like used for PSO) @RheumNow

Arthur Lau ArthurRheum ( View Tweet)

LB abstract L06: Genovese et al. Filgotinib (JAK1-i) for treatment of RA after biologic failure. ACR 20/50/70 = 70/46/32% by 24 weeks. No GI perforations seen. #ACR18 @RheumNow https://t.co/5rAqz7ljXO

Links:

Suleman Bhana, MD DrBhana ( View Tweet)

Dr. Spiegal: Challenges in usability. in 2015 Cedars-Sinai allowed smartphone data to input into the EHR via Apple’s HealthKit framework. Out of nearly 80,000 invited patents, 499 connected (0.8%) = younger patients, few comorbidites, hospital employees. #ACR18 @Rheumnow https://t.co/HUPtbvGpVL
Suleman Bhana, MD DrBhana ( View Tweet)
Dr. Spiegal: Hyperpersonalize example of an app helping to increase activity level: “Today is a nice day outside, it will be good if you go out and go for a walk.” #ACR18

Suleman Bhana, MD DrBhana ( View Tweet)

Dr. Spiegal: For reference: IDEAS (Integrate, Design, Assess, and Share) Framework and toolkit for development of effective digital interventions for health behavior. Mummah et al. J. Med Internet Research 2016. #ACR18 @RheumNow

Suleman Bhana, MD DrBhana ( View Tweet)

This is an *extremely* important study in ANCA-vasculitis. Looking forward to really digging into this data. #ACR18 https://t.co/OX0YPwQrCD

Links:

Paul Sufka, MD psufka ( View Tweet)

PET CT protocol with high NPV (98%)could be used as a first-line test to rule out GCA vs bx. https://t.co/yQEyQyHcDx @RheumNow #ACR18 L15

Links:

Dr. Rachel Tate uptoTate ( View Tweet)

2828 Utility of Fecal Calprotectin Levels for the Diagnosis of Inflammatory Bowel Disease in Patients with Spondylorarthritis #ACR18 https://t.co/QUPgiwT1dt
Jose Campos JoseCamposMD ( View Tweet)
Dr. Polly Ferguson SAPHO dx criteria, Kahn 2003 including -bone /joint involvement with psoriasis -bone joint with severe acne -isolated steroid hyperostosis/osteeitis -CRMO (children) -bone-joint with IBD excluding: -bone tumor -non inflammatory #ACR18 @RheumNow

Suleman Bhana, MD DrBhana ( View Tweet)

Common patient concern: Humira and pregnancy. IgG does not cross the placenta until 12-15 weeks. Consider discontinuing in late second trimester or early third trimester to avoid high serum drug concentrations in the newborn 🤰🏻 #ACR18 #CleClinicRheum

Emily Littlejohn ELittlejohnDO ( View Tweet)

Dr. Kavanaugh: Abstract 826. https://t.co/X0MKvAO3UV Does Anti-Glomerular Basement (anti-GBM) Antibody Positivity Correlate with Relapse in Patients with Anti-GBM Disease? —Presence of ANCA predicts relapse. #ACR18 @RheumNow

Links:

Suleman Bhana, MD DrBhana ( View Tweet)

Dr. Cush ABSTRACT 898 Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled  Trial —missed RSSS outcome, but improved lung function #ACR18 @Rheumnow https://t.co/E7LdBEfXWc

Links:

Suleman Bhana, MD DrBhana ( View Tweet)

Dr. Kavanaugh: Abstract 1068. Role of Cannabinoid CB2 Receptor Agonist, in IL-1β-Induced Inflammation in RA Synovial Fibroblasts —CB2 therapeutic target #ACR18 @RheumNow https://t.co/fZoPnLKQcjβ-induced-inflammation-in-human-rheumatoid-arthr…

Links:

Suleman Bhana, MD DrBhana ( View Tweet)

×